Allegiance Financial Group Advisory Services LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1964068
VIENNA, VA
Position in NBIX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$490,114
+$63,540 QoQ
Shares Held
2,908
-10.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#476
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Allegiance Financial Group Advisory Services LLC holds $535,897 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (91.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,908 | $490,114 | |
| 2 | IRWD |
Ironwood Pharmaceuticals Inc
|
10,875 | $45,783 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $490,114 | 2,908 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $426,574 | 3,238 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $322,237 | 2,272 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $250,437 | 1,784 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||